

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 7.38996834 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.97508817 |
| 3 | NADH metabolic process (GO:0006734) | 5.91185208 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.49185348 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.49185348 |
| 6 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.39380233 |
| 7 | sarcomere organization (GO:0045214) | 5.25099074 |
| 8 | * respiratory electron transport chain (GO:0022904) | 5.21672988 |
| 9 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.13499241 |
| 10 | lysine metabolic process (GO:0006553) | 5.12207043 |
| 11 | lysine catabolic process (GO:0006554) | 5.12207043 |
| 12 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.11158606 |
| 13 | * electron transport chain (GO:0022900) | 5.08406038 |
| 14 | carnitine shuttle (GO:0006853) | 5.05479570 |
| 15 | succinate metabolic process (GO:0006105) | 4.93016454 |
| 16 | oxidative phosphorylation (GO:0006119) | 4.92152821 |
| 17 | aspartate family amino acid catabolic process (GO:0009068) | 4.84343787 |
| 18 | regulation of coenzyme metabolic process (GO:0051196) | 4.81062624 |
| 19 | regulation of cofactor metabolic process (GO:0051193) | 4.81062624 |
| 20 | Golgi transport vesicle coating (GO:0048200) | 4.80622273 |
| 21 | COPI coating of Golgi vesicle (GO:0048205) | 4.80622273 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.69695258 |
| 23 | cardiac myofibril assembly (GO:0055003) | 4.68601639 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 4.68431774 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 4.65823092 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 4.56565144 |
| 27 | oxaloacetate metabolic process (GO:0006107) | 4.54302973 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.51008055 |
| 29 | proline biosynthetic process (GO:0006561) | 4.47088513 |
| 30 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.33568021 |
| 31 | muscle filament sliding (GO:0030049) | 4.26897001 |
| 32 | actin-myosin filament sliding (GO:0033275) | 4.26897001 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 4.26154491 |
| 34 | myofibril assembly (GO:0030239) | 4.18096414 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.16641052 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.15755536 |
| 37 | regulation of sequestering of triglyceride (GO:0010889) | 4.13849902 |
| 38 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.08732061 |
| 39 | cardiac muscle contraction (GO:0060048) | 4.07963771 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 4.05640501 |
| 41 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.05151392 |
| 42 | fatty acid catabolic process (GO:0009062) | 4.01930023 |
| 43 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.00432289 |
| 44 | GDP-mannose metabolic process (GO:0019673) | 3.98912345 |
| 45 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.98281932 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 3.98128456 |
| 47 | carnitine transmembrane transport (GO:1902603) | 3.95487138 |
| 48 | hexose biosynthetic process (GO:0019319) | 3.95027023 |
| 49 | monosaccharide biosynthetic process (GO:0046364) | 3.94959483 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 3.92822009 |
| 51 | fatty acid oxidation (GO:0019395) | 3.91182383 |
| 52 | amino-acid betaine transport (GO:0015838) | 3.90675308 |
| 53 | carnitine transport (GO:0015879) | 3.90675308 |
| 54 | protein maturation by protein folding (GO:0022417) | 3.89916043 |
| 55 | lipid oxidation (GO:0034440) | 3.82858138 |
| 56 | short-chain fatty acid metabolic process (GO:0046459) | 3.82030885 |
| 57 | regulation of skeletal muscle contraction (GO:0014819) | 3.81782696 |
| 58 | glycolytic process (GO:0006096) | 3.80817478 |
| 59 | negative regulation of cell size (GO:0045792) | 3.79188670 |
| 60 | branched-chain amino acid metabolic process (GO:0009081) | 3.78331072 |
| 61 | regulation of fatty acid oxidation (GO:0046320) | 3.77014368 |
| 62 | regulation of sulfur metabolic process (GO:0042762) | 3.76225791 |
| 63 | ATP biosynthetic process (GO:0006754) | 3.72537413 |
| 64 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.65348111 |
| 65 | glyoxylate metabolic process (GO:0046487) | 3.60252435 |
| 66 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.55060386 |
| 67 | monocarboxylic acid catabolic process (GO:0072329) | 3.52814559 |
| 68 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.52483934 |
| 69 | mitochondrial fusion (GO:0008053) | 3.49763441 |
| 70 | cardiac muscle cell development (GO:0055013) | 3.47466045 |
| 71 | ketone body metabolic process (GO:1902224) | 3.43693533 |
| 72 | actin-mediated cell contraction (GO:0070252) | 3.41856208 |
| 73 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.39799239 |
| 74 | regulation of actin filament-based movement (GO:1903115) | 3.39600623 |
| 75 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.39438065 |
| 76 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.38355299 |
| 77 | inner mitochondrial membrane organization (GO:0007007) | 3.38066374 |
| 78 | biotin metabolic process (GO:0006768) | 3.35567499 |
| 79 | valine metabolic process (GO:0006573) | 3.34428246 |
| 80 | regulation of translational fidelity (GO:0006450) | 3.34367890 |
| 81 | pentose-phosphate shunt (GO:0006098) | 3.34205917 |
| 82 | L-phenylalanine metabolic process (GO:0006558) | 3.33197775 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.33197775 |
| 84 | carnitine metabolic process (GO:0009437) | 3.32619228 |
| 85 | heart process (GO:0003015) | 3.32485483 |
| 86 | heart contraction (GO:0060047) | 3.32485483 |
| 87 | plasma membrane repair (GO:0001778) | 3.30920071 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.29049705 |
| 89 | quaternary ammonium group transport (GO:0015697) | 3.25943667 |
| 90 | cardiac muscle hypertrophy (GO:0003300) | 3.25567871 |
| 91 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.24511138 |
| 92 | striated muscle contraction (GO:0006941) | 3.23086203 |
| 93 | proline metabolic process (GO:0006560) | 3.21631784 |
| 94 | quinone biosynthetic process (GO:1901663) | 3.19682100 |
| 95 | ubiquinone biosynthetic process (GO:0006744) | 3.19682100 |
| 96 | actomyosin structure organization (GO:0031032) | 3.19527240 |
| 97 | cardiac cell development (GO:0055006) | 3.18992681 |
| 98 | formation of translation preinitiation complex (GO:0001731) | 3.18903929 |
| 99 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.18224237 |
| 100 | gluconeogenesis (GO:0006094) | 3.17550964 |
| 101 | protein retention in ER lumen (GO:0006621) | 3.16876549 |
| 102 | regulation of mitochondrial translation (GO:0070129) | 3.15767643 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 3.15391632 |
| 104 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.15030311 |
| 105 | L-phenylalanine catabolic process (GO:0006559) | 3.15030311 |
| 106 | regulation of relaxation of muscle (GO:1901077) | 3.14740921 |
| 107 | creatine metabolic process (GO:0006600) | 3.13272374 |
| 108 | regulation of cell communication by electrical coupling (GO:0010649) | 3.10966888 |
| 109 | striated muscle hypertrophy (GO:0014897) | 3.09022034 |
| 110 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.08721408 |
| 111 | cell communication involved in cardiac conduction (GO:0086065) | 3.08468199 |
| 112 | positive regulation of fatty acid oxidation (GO:0046321) | 3.08023153 |
| 113 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.06592318 |
| 114 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.05198438 |
| 115 | adult heart development (GO:0007512) | 3.03610961 |
| 116 | heart trabecula formation (GO:0060347) | 3.03496556 |
| 117 | peptidyl-arginine methylation (GO:0018216) | 3.03492338 |
| 118 | peptidyl-arginine N-methylation (GO:0035246) | 3.03492338 |
| 119 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03143123 |
| 120 | regulation of oxidative phosphorylation (GO:0002082) | 3.01491841 |
| 121 | glucose catabolic process (GO:0006007) | 3.00846155 |
| 122 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.99940200 |
| 123 | histone arginine methylation (GO:0034969) | 2.99167070 |
| 124 | regulation of membrane repolarization (GO:0060306) | 2.99027289 |
| 125 | regulation of sarcomere organization (GO:0060297) | 2.97722513 |
| 126 | aerobic respiration (GO:0009060) | 2.97638756 |
| 127 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.97518017 |
| 128 | DNA unwinding involved in DNA replication (GO:0006268) | 2.91874857 |
| 129 | fructose metabolic process (GO:0006000) | 2.90789309 |
| 130 | nuclear envelope reassembly (GO:0031468) | 2.88479999 |
| 131 | mitotic nuclear envelope reassembly (GO:0007084) | 2.88479999 |
| 132 | NADPH regeneration (GO:0006740) | 2.88243980 |
| 133 | iron-sulfur cluster assembly (GO:0016226) | 2.82944798 |
| 134 | metallo-sulfur cluster assembly (GO:0031163) | 2.82944798 |
| 135 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.80567687 |
| 136 | pyruvate metabolic process (GO:0006090) | 2.80307733 |
| 137 | galactose catabolic process (GO:0019388) | 2.78156173 |
| 138 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.76951972 |
| 139 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.76951972 |
| 140 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.73617139 |
| 141 | 4-hydroxyproline metabolic process (GO:0019471) | 2.72894947 |
| 142 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.71778864 |
| 143 | skeletal muscle contraction (GO:0003009) | 2.71777869 |
| 144 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.68725898 |
| 145 | nucleotide salvage (GO:0043173) | 2.68124653 |
| 146 | regulation of cellular respiration (GO:0043457) | 2.65731307 |
| 147 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.62689549 |
| 148 | DNA strand elongation (GO:0022616) | 2.60904631 |
| 149 | glucose metabolic process (GO:0006006) | 2.60455060 |
| 150 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.56854594 |
| 151 | negative regulation of necroptotic process (GO:0060546) | 2.56836634 |
| 152 | UV protection (GO:0009650) | 2.56082336 |
| 153 | regulation of superoxide anion generation (GO:0032928) | 2.53658727 |
| 154 | pentose metabolic process (GO:0019321) | 2.51621942 |
| 155 | glucose 6-phosphate metabolic process (GO:0051156) | 2.51387918 |
| 156 | heme biosynthetic process (GO:0006783) | 2.50063844 |
| 157 | folic acid metabolic process (GO:0046655) | 2.46329253 |
| 158 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.45323862 |
| 159 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.43385678 |
| 160 | negative regulation of necrotic cell death (GO:0060547) | 2.43016471 |
| 161 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.42448125 |
| 162 | regulation of mitochondrial membrane potential (GO:0051881) | 2.36173742 |
| 163 | apoptotic process involved in morphogenesis (GO:0060561) | 2.35040329 |
| 164 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.34825725 |
| 165 | transcription from mitochondrial promoter (GO:0006390) | 2.34310976 |
| 166 | purine nucleotide salvage (GO:0032261) | 2.33161772 |
| 167 | barbed-end actin filament capping (GO:0051016) | 2.32958778 |
| 168 | pinocytosis (GO:0006907) | 2.32835174 |
| 169 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.32393087 |
| 170 | nitrogen cycle metabolic process (GO:0071941) | 2.31387338 |
| 171 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.30167692 |
| 172 | hexose metabolic process (GO:0019318) | 2.29771997 |
| 173 | urea cycle (GO:0000050) | 2.27430190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.50332952 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.44846501 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.03280242 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.30577562 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.99774099 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.75454926 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06639575 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05205789 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53135768 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.41540979 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.38953788 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.37478442 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.19114798 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17860131 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.13510330 |
| 16 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.12248636 |
| 17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.05426567 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05002767 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.96670917 |
| 20 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.93720994 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87961910 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86712853 |
| 23 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.85356912 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.85356912 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83653824 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81593920 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78185374 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.77269266 |
| 29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73544965 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71714146 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70356131 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69994151 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67043922 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.65388342 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.64396841 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.64105659 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63337859 |
| 38 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59494804 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.58718343 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.56472311 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48653981 |
| 42 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47124328 |
| 43 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47116640 |
| 44 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.46831859 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45803605 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44546463 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42721497 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41949280 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.40166651 |
| 50 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40092340 |
| 51 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39826831 |
| 52 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38585928 |
| 53 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37927683 |
| 54 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37765747 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37565953 |
| 56 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37074060 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37051457 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36629147 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35914077 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35059249 |
| 61 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.34803058 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34432296 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33219419 |
| 64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32263083 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31726163 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30514343 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30513418 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30411131 |
| 69 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30280590 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.26997499 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26838957 |
| 72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26384424 |
| 73 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24231123 |
| 74 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.23887914 |
| 75 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22260866 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20325108 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17648019 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17431960 |
| 79 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16860971 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15639018 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15136277 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14489407 |
| 83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14141495 |
| 84 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14093623 |
| 85 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.12237769 |
| 86 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11657064 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.11584800 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10534596 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09789497 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08676644 |
| 91 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.07674187 |
| 92 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07092819 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06965315 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 1.06935322 |
| 95 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06179872 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06137336 |
| 97 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05994983 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05331732 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05170941 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04658707 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04185255 |
| 102 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.03007146 |
| 103 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02442214 |
| 104 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01507398 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01476505 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 0.97414593 |
| 107 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.96906692 |
| 108 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.93753258 |
| 109 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93628834 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93158982 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92585075 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91849142 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91015555 |
| 114 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87918301 |
| 115 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.87499433 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87113599 |
| 117 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86876719 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86474646 |
| 119 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85501339 |
| 120 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84925294 |
| 121 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84631479 |
| 122 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84169815 |
| 123 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83238753 |
| 124 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.83121859 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82719797 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82233733 |
| 127 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.80765655 |
| 128 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.80375907 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80026884 |
| 130 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.79298671 |
| 131 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78336217 |
| 132 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.77549471 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77211318 |
| 134 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.77183949 |
| 135 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.76365226 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73518429 |
| 137 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.73460977 |
| 138 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.73140111 |
| 139 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.70964508 |
| 140 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70533695 |
| 141 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.69827307 |
| 142 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.69577619 |
| 143 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.69558085 |
| 144 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.69075872 |
| 145 | ERA_21632823_ChIP-Seq_H3396_Human | 0.68396271 |
| 146 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.68033810 |
| 147 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.67597537 |
| 148 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.66964125 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.66578870 |
| 150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65942008 |
| 151 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.65912571 |
| 152 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65179172 |
| 153 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.64995440 |
| 154 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.64339980 |
| 155 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.63927635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.02615058 |
| 2 | MP0003646_muscle_fatigue | 4.75860521 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.12028008 |
| 4 | MP0000751_myopathy | 4.05505511 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.71124308 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.46105016 |
| 7 | MP0000749_muscle_degeneration | 3.20209326 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.20016506 |
| 9 | MP0005330_cardiomyopathy | 3.16156240 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.88789509 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.77654009 |
| 12 | MP0005360_urolithiasis | 2.72391170 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.68797629 |
| 14 | MP0004130_abnormal_muscle_cell | 2.61408431 |
| 15 | MP0008260_abnormal_autophagy | 2.41442050 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.35159542 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.35071868 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.32749891 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.31845904 |
| 20 | MP0005620_abnormal_muscle_contractility | 2.20749260 |
| 21 | MP0003137_abnormal_impulse_conducting | 2.13118374 |
| 22 | MP0002269_muscular_atrophy | 2.08898652 |
| 23 | MP0005670_abnormal_white_adipose | 2.05737166 |
| 24 | MP0005365_abnormal_bile_salt | 2.01466263 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 1.99815360 |
| 26 | MP0001544_abnormal_cardiovascular_syste | 1.94045047 |
| 27 | MP0005385_cardiovascular_system_phenoty | 1.94045047 |
| 28 | MP0004043_abnormal_pH_regulation | 1.91987103 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.90279005 |
| 30 | MP0005332_abnormal_amino_acid | 1.88365669 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87425675 |
| 32 | MP0001661_extended_life_span | 1.87306096 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.86150952 |
| 34 | MP0000747_muscle_weakness | 1.85474298 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.83085222 |
| 36 | MP0002822_catalepsy | 1.81892816 |
| 37 | MP0006138_congestive_heart_failure | 1.80090393 |
| 38 | MP0004484_altered_response_of | 1.80072951 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.75547156 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75278949 |
| 41 | MP0004085_abnormal_heartbeat | 1.68863400 |
| 42 | MP0003195_calcinosis | 1.67914082 |
| 43 | MP0003111_abnormal_nucleus_morphology | 1.63259233 |
| 44 | MP0010630_abnormal_cardiac_muscle | 1.62075187 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.56684916 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.55835139 |
| 47 | MP0004233_abnormal_muscle_weight | 1.51501650 |
| 48 | MP0005369_muscle_phenotype | 1.48690837 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.48321027 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.45493095 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.42015056 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.40369866 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.40153109 |
| 54 | MP0009278_abnormal_bone_marrow | 1.27294678 |
| 55 | MP0003693_abnormal_embryo_hatching | 1.26183077 |
| 56 | MP0004858_abnormal_nervous_system | 1.25362948 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.24121362 |
| 58 | MP0000678_abnormal_parathyroid_gland | 1.22622437 |
| 59 | MP0005083_abnormal_biliary_tract | 1.21479164 |
| 60 | MP0002971_abnormal_brown_adipose | 1.17982197 |
| 61 | MP0005535_abnormal_body_temperature | 1.16909772 |
| 62 | MP0005266_abnormal_metabolism | 1.16803417 |
| 63 | MP0010094_abnormal_chromosome_stability | 1.16258260 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.16254607 |
| 65 | MP0009840_abnormal_foam_cell | 1.16042956 |
| 66 | MP0005375_adipose_tissue_phenotype | 1.15285303 |
| 67 | MP0002127_abnormal_cardiovascular_syste | 1.14621554 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14368884 |
| 69 | MP0003077_abnormal_cell_cycle | 1.11773248 |
| 70 | MP0000733_abnormal_muscle_development | 1.08392539 |
| 71 | MP0000358_abnormal_cell_content/ | 1.07980133 |
| 72 | MP0001730_embryonic_growth_arrest | 1.07968569 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.05753501 |
| 74 | MP0003252_abnormal_bile_duct | 1.02916448 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.01710750 |
| 76 | MP0005451_abnormal_body_composition | 0.99904869 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 0.98777359 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.97896264 |
| 79 | MP0003950_abnormal_plasma_membrane | 0.97339981 |
| 80 | MP0004859_abnormal_synaptic_plasticity | 0.96298871 |
| 81 | MP0008932_abnormal_embryonic_tissue | 0.95416159 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.94689628 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 0.92852443 |
| 84 | MP0001666_abnormal_nutrient_absorption | 0.91645739 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.91639382 |
| 86 | MP0003186_abnormal_redox_activity | 0.89340400 |
| 87 | MP0005165_increased_susceptibility_to | 0.87535284 |
| 88 | MP0004147_increased_porphyrin_level | 0.85448992 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.85380662 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.84062105 |
| 91 | MP0001764_abnormal_homeostasis | 0.83954407 |
| 92 | MP0000313_abnormal_cell_death | 0.82463948 |
| 93 | MP0003329_amyloid_beta_deposits | 0.82025712 |
| 94 | MP0001849_ear_inflammation | 0.81272360 |
| 95 | MP0003075_altered_response_to | 0.81261679 |
| 96 | MP0001853_heart_inflammation | 0.81056573 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.80781133 |
| 98 | MP0005501_abnormal_skin_physiology | 0.80547109 |
| 99 | MP0002909_abnormal_adrenal_gland | 0.79624465 |
| 100 | MP0001529_abnormal_vocalization | 0.78679224 |
| 101 | MP0003828_pulmonary_edema | 0.77184935 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.75978393 |
| 103 | MP0003786_premature_aging | 0.74899969 |
| 104 | MP0002080_prenatal_lethality | 0.74776387 |
| 105 | MP0000604_amyloidosis | 0.73392609 |
| 106 | MP0001873_stomach_inflammation | 0.71789004 |
| 107 | MP0000609_abnormal_liver_physiology | 0.71351553 |
| 108 | MP0008874_decreased_physiological_sensi | 0.70837154 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.69462188 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.67735729 |
| 111 | MP0008569_lethality_at_weaning | 0.66171802 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.66120517 |
| 113 | MP0002132_abnormal_respiratory_system | 0.65722789 |
| 114 | MP0001756_abnormal_urination | 0.65583906 |
| 115 | MP0000858_altered_metastatic_potential | 0.65377858 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.65282292 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.64506083 |
| 118 | MP0005166_decreased_susceptibility_to | 0.62854125 |
| 119 | MP0004924_abnormal_behavior | 0.61811929 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.61811929 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.61228389 |
| 122 | MP0000343_altered_response_to | 0.59063713 |
| 123 | MP0000266_abnormal_heart_morphology | 0.59007241 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.58855318 |
| 125 | MP0002108_abnormal_muscle_morphology | 0.58834376 |
| 126 | MP0005448_abnormal_energy_balance | 0.58375560 |
| 127 | MP0004019_abnormal_vitamin_homeostasis | 0.57864038 |
| 128 | MP0005334_abnormal_fat_pad | 0.54486927 |
| 129 | MP0005452_abnormal_adipose_tissue | 0.53905476 |
| 130 | MP0002272_abnormal_nervous_system | 0.52808877 |
| 131 | MP0002234_abnormal_pharynx_morphology | 0.51710628 |
| 132 | MP0004510_myositis | 0.51092493 |
| 133 | MP0002970_abnormal_white_adipose | 0.50882547 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.50254708 |
| 135 | MP0003705_abnormal_hypodermis_morpholog | 0.49629901 |
| 136 | MP0004142_abnormal_muscle_tone | 0.47644351 |
| 137 | MP0008872_abnormal_physiological_respon | 0.47118377 |
| 138 | MP0003953_abnormal_hormone_level | 0.45929323 |
| 139 | MP0010368_abnormal_lymphatic_system | 0.45330717 |
| 140 | MP0001727_abnormal_embryo_implantation | 0.40997200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.26458315 |
| 2 | Myoglobinuria (HP:0002913) | 4.81490806 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.69081905 |
| 4 | Hepatic necrosis (HP:0002605) | 4.46542146 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 4.33793323 |
| 6 | Myopathic facies (HP:0002058) | 4.33669440 |
| 7 | * Abnormal mitochondria in muscle tissue (HP:0008316) | 4.27203164 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.20830794 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.18768401 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.17855255 |
| 11 | * Acute necrotizing encephalopathy (HP:0006965) | 4.15373603 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 4.11566323 |
| 13 | * Acute encephalopathy (HP:0006846) | 4.08000236 |
| 14 | Hepatocellular necrosis (HP:0001404) | 4.07393213 |
| 15 | Nemaline bodies (HP:0003798) | 4.03803195 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.00816841 |
| 17 | Rhabdomyolysis (HP:0003201) | 3.98993152 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.93437866 |
| 19 | Palpitations (HP:0001962) | 3.92867150 |
| 20 | * Cerebral edema (HP:0002181) | 3.80284890 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.74856433 |
| 22 | Increased serum pyruvate (HP:0003542) | 3.74470967 |
| 23 | Abnormality of glycolysis (HP:0004366) | 3.74470967 |
| 24 | Muscle fiber splitting (HP:0003555) | 3.72011029 |
| 25 | Ketoacidosis (HP:0001993) | 3.62047193 |
| 26 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.61005241 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 3.61005241 |
| 28 | * Mitochondrial inheritance (HP:0001427) | 3.59759271 |
| 29 | Distal lower limb muscle weakness (HP:0009053) | 3.56802610 |
| 30 | Atrial fibrillation (HP:0005110) | 3.52124862 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.48712918 |
| 32 | * Increased CSF lactate (HP:0002490) | 3.47062837 |
| 33 | Ketosis (HP:0001946) | 3.42771846 |
| 34 | * Progressive macrocephaly (HP:0004481) | 3.40421484 |
| 35 | Lipoatrophy (HP:0100578) | 3.39770982 |
| 36 | Increased muscle lipid content (HP:0009058) | 3.38404812 |
| 37 | Hyperglycinuria (HP:0003108) | 3.35612660 |
| 38 | Abnormality of the calf musculature (HP:0001430) | 3.34791418 |
| 39 | Distal lower limb amyotrophy (HP:0008944) | 3.30243848 |
| 40 | Hyperammonemia (HP:0001987) | 3.28744503 |
| 41 | Pheochromocytoma (HP:0002666) | 3.27619798 |
| 42 | Progressive muscle weakness (HP:0003323) | 3.26352707 |
| 43 | Primary atrial arrhythmia (HP:0001692) | 3.26238444 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 3.26014537 |
| 45 | * Lactic acidosis (HP:0003128) | 3.23490210 |
| 46 | Supraventricular tachycardia (HP:0004755) | 3.20021284 |
| 47 | Syncope (HP:0001279) | 3.19299641 |
| 48 | Supraventricular arrhythmia (HP:0005115) | 3.14541711 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 3.08185322 |
| 50 | Microvesicular hepatic steatosis (HP:0001414) | 3.02495812 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.01297988 |
| 52 | Abnormality of glycine metabolism (HP:0010895) | 3.01297988 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.99442162 |
| 54 | Dilated cardiomyopathy (HP:0001644) | 2.98295812 |
| 55 | Neuroendocrine neoplasm (HP:0100634) | 2.97772242 |
| 56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.94999015 |
| 57 | Ragged-red muscle fibers (HP:0003200) | 2.88821884 |
| 58 | Conjunctival hamartoma (HP:0100780) | 2.84384044 |
| 59 | Bundle branch block (HP:0011710) | 2.82585342 |
| 60 | * Lethargy (HP:0001254) | 2.79486186 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 2.77248936 |
| 62 | * Respiratory failure (HP:0002878) | 2.76465404 |
| 63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.76348907 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.75954390 |
| 65 | Prolonged QT interval (HP:0001657) | 2.71651380 |
| 66 | Ventricular arrhythmia (HP:0004308) | 2.64867139 |
| 67 | * Exercise intolerance (HP:0003546) | 2.64482313 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.63001192 |
| 69 | Neck muscle weakness (HP:0000467) | 2.62711119 |
| 70 | Myotonia (HP:0002486) | 2.60748544 |
| 71 | Increased connective tissue (HP:0009025) | 2.59272364 |
| 72 | Muscle stiffness (HP:0003552) | 2.58548358 |
| 73 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.56652325 |
| 74 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.56652325 |
| 75 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.55155902 |
| 76 | Metabolic acidosis (HP:0001942) | 2.54832758 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.53450430 |
| 78 | Hyperalaninemia (HP:0003348) | 2.53450430 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.53450430 |
| 80 | Gout (HP:0001997) | 2.51462819 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.50215183 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.48093818 |
| 83 | Increased serum lactate (HP:0002151) | 2.47569141 |
| 84 | Heart block (HP:0012722) | 2.47423841 |
| 85 | Hyperglycinemia (HP:0002154) | 2.46045249 |
| 86 | Reticulocytosis (HP:0001923) | 2.45642115 |
| 87 | Difficulty running (HP:0009046) | 2.45459791 |
| 88 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.44471776 |
| 89 | Subaortic stenosis (HP:0001682) | 2.44471776 |
| 90 | Difficulty climbing stairs (HP:0003551) | 2.40437931 |
| 91 | Lipid accumulation in hepatocytes (HP:0006561) | 2.40274634 |
| 92 | Atrioventricular block (HP:0001678) | 2.39120158 |
| 93 | Stridor (HP:0010307) | 2.35641548 |
| 94 | Truncus arteriosus (HP:0001660) | 2.35575844 |
| 95 | CNS demyelination (HP:0007305) | 2.33724496 |
| 96 | Distal upper limb amyotrophy (HP:0007149) | 2.33438697 |
| 97 | Upper limb amyotrophy (HP:0009129) | 2.33438697 |
| 98 | Cholelithiasis (HP:0001081) | 2.32961548 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.31180278 |
| 100 | * Vomiting (HP:0002013) | 2.30395774 |
| 101 | Seborrheic dermatitis (HP:0001051) | 2.26048054 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 2.25798785 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 2.25623130 |
| 104 | Lower limb amyotrophy (HP:0007210) | 2.25601129 |
| 105 | Hyperthyroidism (HP:0000836) | 2.22932708 |
| 106 | Hypertensive crisis (HP:0100735) | 2.21409034 |
| 107 | Abnormality of the foot musculature (HP:0001436) | 2.20152827 |
| 108 | Cerebral palsy (HP:0100021) | 2.20124642 |
| 109 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19936970 |
| 110 | Neoplasm of the adrenal gland (HP:0100631) | 2.18879579 |
| 111 | Proximal tubulopathy (HP:0000114) | 2.17985766 |
| 112 | Methylmalonic aciduria (HP:0012120) | 2.15879313 |
| 113 | Vertebral compression fractures (HP:0002953) | 2.14172093 |
| 114 | Esophageal neoplasm (HP:0100751) | 2.14111802 |
| 115 | Neoplasm of head and neck (HP:0012288) | 2.14111802 |
| 116 | Abnormal gallbladder morphology (HP:0012437) | 2.12213476 |
| 117 | Athetosis (HP:0002305) | 2.12133942 |
| 118 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.11630532 |
| 119 | Rimmed vacuoles (HP:0003805) | 2.10944067 |
| 120 | Testicular atrophy (HP:0000029) | 2.08558451 |
| 121 | Bulbar palsy (HP:0001283) | 2.08492358 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 2.07375425 |
| 123 | Cholecystitis (HP:0001082) | 2.07375425 |
| 124 | Nausea (HP:0002018) | 2.07086772 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06375535 |
| 126 | Abnormality of the tricuspid valve (HP:0001702) | 2.05651579 |
| 127 | Abnormality of serum amino acid levels (HP:0003112) | 2.03706136 |
| 128 | Hyperacusis (HP:0010780) | 2.01699946 |
| 129 | Emotional lability (HP:0000712) | 2.01670381 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 2.01375888 |
| 131 | * Leukodystrophy (HP:0002415) | 2.00620978 |
| 132 | Left ventricular hypertrophy (HP:0001712) | 1.98813442 |
| 133 | Xanthomatosis (HP:0000991) | 1.98190791 |
| 134 | Abnormal EKG (HP:0003115) | 1.97654891 |
| 135 | * Optic disc pallor (HP:0000543) | 1.97442574 |
| 136 | Glycosuria (HP:0003076) | 1.96800922 |
| 137 | EMG: neuropathic changes (HP:0003445) | 1.96166643 |
| 138 | Hypokinesia (HP:0002375) | 1.93114565 |
| 139 | Abnormality of the gallbladder (HP:0005264) | 1.92751369 |
| 140 | Round ear (HP:0100830) | 1.90956295 |
| 141 | Ulnar deviation of the wrist (HP:0003049) | 1.90530032 |
| 142 | Progressive external ophthalmoplegia (HP:0000590) | 1.89703840 |
| 143 | Diaphragmatic weakness (HP:0009113) | 1.87322238 |
| 144 | Abnormality of reticulocytes (HP:0004312) | 1.87016131 |
| 145 | Limb-girdle muscle atrophy (HP:0003797) | 1.86331168 |
| 146 | Insomnia (HP:0100785) | 1.81178844 |
| 147 | Calcaneovalgus deformity (HP:0001848) | 1.81028511 |
| 148 | Fatigue (HP:0012378) | 1.80892172 |
| 149 | Ankle clonus (HP:0011448) | 1.79769012 |
| 150 | Hand muscle atrophy (HP:0009130) | 1.79572346 |
| 151 | Trismus (HP:0000211) | 1.79132386 |
| 152 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.77483325 |
| 153 | Spastic paraparesis (HP:0002313) | 1.74594952 |
| 154 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73708697 |
| 155 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73708697 |
| 156 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73708697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.30013373 |
| 2 | PDK4 | 4.69059906 |
| 3 | PDK3 | 4.69059906 |
| 4 | TTN | 3.90173192 |
| 5 | OBSCN | 3.77353586 |
| 6 | LMTK2 | 3.40241376 |
| 7 | MYLK | 3.31360779 |
| 8 | NEK1 | 3.16609432 |
| 9 | PHKG1 | 3.13575782 |
| 10 | PHKG2 | 3.13575782 |
| 11 | TESK2 | 3.08725844 |
| 12 | PDK2 | 2.78603476 |
| 13 | SMG1 | 2.71024789 |
| 14 | TESK1 | 2.65806064 |
| 15 | TRIB3 | 2.51856030 |
| 16 | EEF2K | 2.32987177 |
| 17 | PINK1 | 2.23946613 |
| 18 | PKN2 | 2.17515610 |
| 19 | SCYL2 | 2.09151876 |
| 20 | VRK2 | 2.06397335 |
| 21 | IRAK3 | 2.02211809 |
| 22 | ICK | 1.94473606 |
| 23 | ERN1 | 1.93682392 |
| 24 | PIK3CA | 1.90962240 |
| 25 | WNK4 | 1.89222414 |
| 26 | PRPF4B | 1.88297905 |
| 27 | NME1 | 1.70069233 |
| 28 | PIM2 | 1.60838531 |
| 29 | EPHA2 | 1.49852255 |
| 30 | TIE1 | 1.32177195 |
| 31 | CAMK2D | 1.25872637 |
| 32 | MAP2K4 | 1.25788651 |
| 33 | STK24 | 1.22499156 |
| 34 | MUSK | 1.18864718 |
| 35 | STK38L | 1.15633409 |
| 36 | PAK3 | 1.12413705 |
| 37 | ILK | 1.11271001 |
| 38 | DAPK3 | 1.09885967 |
| 39 | TBK1 | 1.06953796 |
| 40 | MAP3K4 | 1.06699762 |
| 41 | PRKD3 | 1.05763805 |
| 42 | DMPK | 0.95864005 |
| 43 | OXSR1 | 0.94323488 |
| 44 | STK39 | 0.93695993 |
| 45 | RPS6KB2 | 0.91801156 |
| 46 | MAP2K3 | 0.90734610 |
| 47 | MAPK12 | 0.87382819 |
| 48 | TAOK2 | 0.86358000 |
| 49 | GRK7 | 0.86156702 |
| 50 | CAMK2G | 0.83074238 |
| 51 | PAK4 | 0.82265809 |
| 52 | PBK | 0.81595174 |
| 53 | PTK2B | 0.81233311 |
| 54 | AURKA | 0.80361825 |
| 55 | MAP3K8 | 0.78528245 |
| 56 | MAPKAPK3 | 0.77553824 |
| 57 | PRKD1 | 0.77442376 |
| 58 | EIF2AK1 | 0.75717808 |
| 59 | CAMK2A | 0.72106665 |
| 60 | RIPK4 | 0.71991612 |
| 61 | RAF1 | 0.71309935 |
| 62 | TNK2 | 0.70031716 |
| 63 | LIMK1 | 0.69788051 |
| 64 | CDK19 | 0.68993644 |
| 65 | BRSK1 | 0.68752675 |
| 66 | PRKAA1 | 0.68515333 |
| 67 | WNK3 | 0.67459590 |
| 68 | ARAF | 0.67183825 |
| 69 | ROCK1 | 0.67077255 |
| 70 | LRRK2 | 0.67031281 |
| 71 | MST1R | 0.66994531 |
| 72 | PDPK1 | 0.66288038 |
| 73 | SIK2 | 0.65826507 |
| 74 | SGK494 | 0.65514208 |
| 75 | SGK223 | 0.65514208 |
| 76 | MAP3K7 | 0.65277351 |
| 77 | MAP4K1 | 0.63191153 |
| 78 | MAP2K1 | 0.62003657 |
| 79 | CDC42BPA | 0.59847157 |
| 80 | KDR | 0.58847618 |
| 81 | NME2 | 0.57906745 |
| 82 | MAP2K2 | 0.55662839 |
| 83 | PAK1 | 0.55330282 |
| 84 | DAPK2 | 0.55120313 |
| 85 | PRKAA2 | 0.54651959 |
| 86 | BRAF | 0.54503992 |
| 87 | CDK7 | 0.54450515 |
| 88 | MAP3K6 | 0.53376773 |
| 89 | MAP3K3 | 0.53067406 |
| 90 | MAP3K11 | 0.52822376 |
| 91 | CDK11A | 0.52354761 |
| 92 | EPHA4 | 0.52289618 |
| 93 | ROCK2 | 0.52285005 |
| 94 | PRKACG | 0.52073599 |
| 95 | FLT3 | 0.52049235 |
| 96 | CAMK2B | 0.50950932 |
| 97 | INSRR | 0.50948366 |
| 98 | PRKCI | 0.50776848 |
| 99 | FGFR4 | 0.50257315 |
| 100 | CDK4 | 0.50245035 |
| 101 | PRKACA | 0.49512607 |
| 102 | PRKACB | 0.48747269 |
| 103 | BMX | 0.48624685 |
| 104 | MARK2 | 0.48010184 |
| 105 | SIK1 | 0.47417448 |
| 106 | STK16 | 0.46184074 |
| 107 | MAP3K5 | 0.45810664 |
| 108 | CAMK4 | 0.45188288 |
| 109 | MTOR | 0.45144688 |
| 110 | CDK15 | 0.45085472 |
| 111 | PKN1 | 0.44906679 |
| 112 | MAP3K12 | 0.44895148 |
| 113 | MAP2K6 | 0.44808439 |
| 114 | FER | 0.44495548 |
| 115 | MAP3K13 | 0.43399199 |
| 116 | CAMKK1 | 0.42275376 |
| 117 | MAP3K1 | 0.42065305 |
| 118 | BUB1 | 0.42022602 |
| 119 | PDK1 | 0.41781387 |
| 120 | AURKB | 0.41705752 |
| 121 | TTK | 0.40632842 |
| 122 | STK38 | 0.40559452 |
| 123 | MINK1 | 0.40481748 |
| 124 | CCNB1 | 0.40300514 |
| 125 | PRKCE | 0.40241569 |
| 126 | PTK6 | 0.38863637 |
| 127 | CDK14 | 0.38240041 |
| 128 | CDK18 | 0.38169028 |
| 129 | NTRK1 | 0.37136443 |
| 130 | RIPK1 | 0.36426309 |
| 131 | KSR2 | 0.36119658 |
| 132 | EPHB1 | 0.35550866 |
| 133 | ATR | 0.35068300 |
| 134 | PRKD2 | 0.33859748 |
| 135 | AKT2 | 0.33794974 |
| 136 | DAPK1 | 0.32988797 |
| 137 | UHMK1 | 0.32341848 |
| 138 | MET | 0.32153842 |
| 139 | ABL2 | 0.31376863 |
| 140 | CSNK1G3 | 0.31354063 |
| 141 | TSSK6 | 0.29733779 |
| 142 | PIK3CG | 0.29409094 |
| 143 | GRK5 | 0.28331741 |
| 144 | CAMK1 | 0.27492983 |
| 145 | MAPK11 | 0.27161741 |
| 146 | WNK1 | 0.27016006 |
| 147 | PRKCG | 0.26960688 |
| 148 | CASK | 0.25182365 |
| 149 | PAK6 | 0.24758233 |
| 150 | ZAK | 0.24714092 |
| 151 | LATS2 | 0.23862271 |
| 152 | SGK3 | 0.21192645 |
| 153 | RPS6KL1 | 0.20443327 |
| 154 | RPS6KC1 | 0.20443327 |
| 155 | ADRBK1 | 0.20314756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.19587227 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.12208860 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.54316089 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20845476 |
| 5 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.18628543 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.01836494 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.97681640 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.94109734 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74574557 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.60724904 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.60492784 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.56492961 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.55338681 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.48665758 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47375291 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35266182 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.18608454 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 2.08472324 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.99497554 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99207290 |
| 21 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.85914887 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83062721 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.68927507 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65043670 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64757407 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60317955 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55103009 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53962869 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45326510 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.41710901 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.40135712 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26609562 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.25818450 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22934200 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.22086107 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19654821 |
| 37 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16023019 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15059227 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13782476 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.12881640 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12225382 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05041883 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03340492 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01759324 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01228644 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97699757 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 0.97528314 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95090671 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 0.82521689 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82245521 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79968309 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79649925 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77795368 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77781873 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76164464 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75737069 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73974055 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72602247 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.72261714 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71961969 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.71830843 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66028337 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65919401 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65911275 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65239506 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64605258 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63737811 |
| 68 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63594860 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61843379 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61726745 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61348010 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59963750 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59937870 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59352011 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58659568 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.58244123 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57501227 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57250794 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52311144 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49492112 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.49226826 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48822227 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46247247 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45021376 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44299974 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42632035 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41921034 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41671011 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37534405 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.37326778 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.37015702 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.37008135 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.36902161 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36815275 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36163459 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34879501 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.34422340 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34232016 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34139614 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33919449 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33243126 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32468723 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32221226 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31667217 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.31534392 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.31269544 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28119217 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27878894 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26392977 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23570011 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23416325 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.22928700 |
| 113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.22702370 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22451147 |
| 115 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.21759785 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21220347 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20798882 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17713253 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17120545 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.17075582 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.16889490 |
| 122 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.16811724 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.16315587 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.15784255 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.14955243 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.14702179 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.12953884 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.12427582 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11673219 |
| 130 | Renin secretion_Homo sapiens_hsa04924 | 0.10854213 |
| 131 | GABAergic synapse_Homo sapiens_hsa04727 | 0.10590072 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.09077119 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08417279 |
| 134 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.04718958 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04556873 |

